38240 Transplt allo hct/donor
Surgery
Also known as: Allogeneic HCT, Bone marrow transplant
Transplantation of allogeneic hematopoietic cells with donor bone marrow or stem cells to establish new hematopoietic function.
Clinical Context
Therapeutic transplantation from matched related or unrelated donor for leukemia, lymphoma, severe aplastic anemia, or immunodeficiency.
RVU Breakdown
| Work RVU | 3.90 |
| Practice Expense RVU | 1.89 |
| Malpractice RVU | 0.25 |
| Total RVU | 6.04 |
Est. Medicare Payment
$201.74
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.